Zebra Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emergent Biosolutions
EBS
|
+$2.15M |
| 2 |
Kelly Services Class A
KELYA
|
+$1.94M |
| 3 |
ESGR
Enstar Group
ESGR
|
+$1.61M |
| 4 |
LCI Industries
LCII
|
+$1.56M |
| 5 |
Upbound Group
UPBD
|
+$1.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WD-40
WDFC
|
+$1.47M |
| 2 |
Corcept Therapeutics
CORT
|
+$1.23M |
| 3 |
Veracyte
VCYT
|
+$1.22M |
| 4 |
Castle Biosciences
CSTL
|
+$1.03M |
| 5 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
+$965K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.12% |
| 2 | Industrials | 15.8% |
| 3 | Financials | 14.75% |
| 4 | Consumer Discretionary | 13.38% |
| 5 | Technology | 12.63% |
Similar funds
Zebra Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Zebra Capital Management held 278 positions worth $90.8M, up 15% from $78.8M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Zebra Capital Management deployed $4.91M of net new capital in Q1 2021, opening 115 new positions and adding to 17 existing holdings. Its largest new stake was Emergent Biosolutions: 20,957 shares worth $1.95M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Veracyte, an estimated $1.22M trimmed.
- Zebra Capital Management's largest Q1 2021 buy was Emergent Biosolutions: 20,957 shares worth $1.95M.
- Zebra Capital Management added most to Rush Enterprises Class A in Q1 2021, an estimated $819K increase.
- Zebra Capital Management's biggest Q1 2021 reduction was Veracyte, cutting an estimated $1.22M.
- Zebra Capital Management fully exited WD-40 in Q1 2021, selling an estimated $1.47M.
- Zebra Capital Management's ten largest holdings make up 18% of its $90.8M portfolio in Q1 2021.
- Zebra Capital Management opened 115 new positions and closed 109 in Q1 2021.
- Zebra Capital Management's portfolio value rose 15% quarter-over-quarter to $90.8M.
Based on Zebra Capital Management's 13F filing for Q1 2021, filed 17 May 2021.